Discover how RWE drives better outcomes for safety and regulatory demands during Signum Morning Briefing.
How can Real World Evidence (RWE) be used strategically in the pharmaceutical industry, for example, for regulatory decisions or to ensure compliance, so approval processes run more smoothly? That is the topic of this Morning Briefing hosted by Signum.
- Hear Novo Nordisk’s take on how RWE supports drug development
- Learn how to apply RWE to understand your patients better (case studies)
- Exchange experiences and challenges with peers
You will gain a solid understanding of RWE as a strategic tool to cut through the regulatory complexity. The event is in Danish but you’re welcome to ask questions in English.
Participation is free.